ADVANCED SOLID TUMOR CANCER
Clinical trials for ADVANCED SOLID TUMOR CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMOR CANCER trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMOR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat cancers: experimental drug targets HER2-positive tumors
Disease control Recruiting nowThis study tests a drug called trastuzumab rezetecan in people with advanced solid tumors that are HER2-positive and have not responded to standard therapies. About 90 participants with three types of cancer (extramammary Paget's disease, rare solid tumors, or urothelial carcinom…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE2 • Sponsor: Sheng Zhang • Aim: Disease control
Last updated May 17, 2026 06:19 UTC
-
X-Ray activated therapy shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests a new treatment called X-PACT for people with advanced head and neck cancer, breast cancer, soft tissue sarcoma, or melanoma that has not responded to standard therapies. The treatment involves injecting a special drug and device directly into the tum…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: Immunolight, LLC • Aim: Disease control
Last updated May 17, 2026 06:19 UTC
-
New drug combo hopes to shrink lung tumors
Disease control Recruiting nowThis early-stage study tests a new drug called HC010 combined with chemotherapy in people with advanced lung cancer. The main goal is to find a safe dose and see if the combination helps control the disease. About 328 participants will take part.
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated May 17, 2026 06:14 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug called HC010 combined with chemotherapy in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goal is to find a safe dose and check for side effects. About 331 participants will take part, and resea…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study is testing a new drug called ABBV-CLS-484, alone or combined with other cancer treatments, in people with advanced solid tumors that have spread or cannot be removed. The main goals are to find safe and tolerable doses and to see if the drug can shrink tumo…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: Calico Life Sciences LLC • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New cancer drug BNT3214 enters first human trials for advanced solid tumors
Disease control Recruiting nowThis study is the first time the experimental drug BNT3214 is being tested in people. It aims to find a safe dose and see if it can shrink tumors in adults with advanced solid cancers that have not responded to other treatments. About 533 participants will take part across multip…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
New combo therapy targets Hard-to-Treat cancers in Mid-Stage trial
Disease control Recruiting nowThis study tests a new drug called LM-24C5 combined with other cancer treatments for people with advanced solid tumors that have a specific protein (CEACAM5). About 130 adults whose cancer has returned or not responded to standard care will participate. The goal is to see if the …
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE2 • Sponsor: LaNova Medicines Limited • Aim: Disease control
Last updated May 07, 2026 18:39 UTC